Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
PharmacoEconomics

01.02.2008 | Practical Application

Modelling Methods for Pharmacoeconomics and Health Technology Assessment

An Overview and Guide

verfasst von: Dr James E. Stahl

Erschienen in: PharmacoEconomics | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

This paper provides an overview of, and guidance as to when, why and how to choose and use, different simulation modelling methods as applied to healthcare. What simulation is and why it is necessary in addressing healthcare problems are discussed. In addition, key criteria for choosing an appropriate method (project type, population resolution, interactivity, treatment of time and space, resource constraints, autonomy and how knowledge is embedded) are covered. Key concepts for each method, moving from the simplest to most complex methods, are reviewed in some detail.
Literatur
1.
Freund D, Dittus R. Principles of pharmac oec onomic analysis of drug therapy. Pharmacoeconomics 1992; 1: 20–31PubMedCrossRef
2.
Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 989–997PubMedCrossRef
3.
Fenton J, Taplin S, Carney P, et al. Influence of computer-aided detection on performance of screening mammography. N Engl J Med 2007; 356: 1399–1409PubMedCrossRef
4.
Boden W, O’Rourke R, Teo K, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 15: 1503–1516CrossRef
5.
Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med 1997; 337: 1003–1005PubMedCrossRef
6.
Hegselmann R, Mueller U, Troitzsch K. Modelling and simulation in the social sciences from the philosophy of science point of view. Dordrecht: Kluwer Academic Publishers, 2005
7.
Morgan M, Morrison M. Models as mediators: perspectives on natural and social science. New York: Cambridge University Press, 1999CrossRef
8.
Kelton W. Experimental design for simulation. Proceedings of the 2000 Winter Simulation Conference; 2000 Dec 10–13; Orlando (FL): 32–38
9.
Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. 1st ed. New York: Oxford University Press, 1996
10.
Law A, Kelton W. Simulation modelling and analysis. New York: McGraw-Hill, 1991
11.
Glenney N, Mac kulak G. Modelling and simulation provide key to CIM implementation philosophy. Ind Eng 1985; 17: 76–94
12.
Stahl J, Rattner D, Wiklund R, et al. Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Dec Making 2004; 24: 461–471CrossRef
13.
Stahl J, Sandberg W, Daily B, et al. Reorganizing patient care and workflow in the operating room: a cost-effectiveness study. Surgery 2006; 139 (6): 717–728PubMedCrossRef
14.
Bateman R, Bowden R, Gogg T, et al. System improvement using simulation. Orem (UT): ProModel Corp, 1997
15.
Shingo S. The Shingo production management system: improving process functions. Cambridge (MA): Productivity Press, 1992
16.
Law A, McComas M. How simulation pays off. J Manufact Engineer 1988; 100: 37–39
17.
Goeller B, Abraham S, Abrahamse A, et al. Policy analysis of water management for the Netherlands: vol. 1. Summary report. Santa Monica (CA): Rand Corporation, 1983
18.
Hancock W, Dissen R, Merten A. An example of simulation to improve plant productivity. AIIE Transactions 1977: 2–10
19.
Freund D, Dittus R. Principles of pharmacoec onomic analysis of drug therapy. Pharmacoeconomics 1992; 1: 20–31PubMedCrossRef
20.
Mitchell M, Jolley J. Research design explained. New York: Harcourt, 2001
21.
Reis H, Judd C. Handbook of research methods in social and personality psychology. Cambridge (UK): Cambridge University Press, 2000
22.
Shadish W, Cook T, Campbell D. Experimental and quasi-experimental designs for generalized causal inference. Boston (MA): Houghton Mifflin, 2002
23.
Nuijten M. The selection of data sources for use in modelling studies. Pharmacoeconomics 1998; 13: 305–316PubMedCrossRef
24.
Nuijten M. Incorporation of statistical uncertainty in health economic modelling studies using second-order Monte Carlo simulations. Pharmacoeconomics 2004; 22: 759–769PubMedCrossRef
25.
Briggs A. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479–500PubMedCrossRef
26.
Halpem E, Weinstein M, Hunink M, et al. Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Dec is Making 2000; 20 (3): 314–322CrossRef
27.
Doubilet P, Begg C, Weinstein M, et al. Probabalistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making, 1985; 5: 157–177PubMedCrossRef
28.
Barton P, Bryan S, Robinson S. Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 2004; 9: 110–118PubMedCrossRef
29.
Brennan A, Chick S, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006; 15: 1295–1310PubMedCrossRef
30.
Plante D, Kassirer J, Zarin D, et al. Clinical decision consultation service. Am J Med 1986; 80: 1169–1176PubMedCrossRef
31.
Barnabas R, Laukkanen P, Koskela P, et al. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med 2006; 3: 624–632CrossRef
32.
Eckman M, Levine H, Salem D, et al. Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest 1998; 114: 699S–714SPubMedCrossRef
33.
Eddy D. The frequency of cervical cancer screening: comparison of a mathematical model with empirical data. Cancer 1987; 60: 1117–1122PubMedCrossRef
34.
US Congress, Office of Technology Assessment. Rural emergency medical services: special report, OTA-H-445. Washington, DC: US Government Printing Office, 1989 Nov
35.
Pritsker A, Martin D, Reust J. Organ transplantation policy evaluation. Proceedings of the Winter Simulation Conference; 1995 Dec 3–6; Arlington (VA): 1314–1323
36.
Stahl J, Roberts M, Gazelle G. Optimizing the management and financial performance of the teaching ambulatory care clinic. J Gen Intern Med 2003; 18: 1–9CrossRef
37.
Zenios S. Modelling the transplant waiting list: a queuing model with reneging. Queuing Systems 1999; 31: 239–251CrossRef
38.
Quaranta V, Weaver A, Cummings P, et al. Mathematical modelling of cancer: the future of prognosis and treatment. Clin Chim Acta 2005; 357: 173–179PubMedCrossRef
39.
Dean B, Gallivan S, Barber N, et al. Mathematical modelling of pharmacy systems. Am J Health Syst Pharm 1997; 54: 2491–2499PubMed
40.
Verma B, Ray S, Srivastava R. Mathematical models and their applications in medicine and health. Health Popul Perspect Issues 1981; 4: 42–58PubMed
41.
England W, Roberts S. Immunization to prevent insulin-dependent diabetes mellitus? The economics of genetic screening and vaccination for diabetes. Ann Intern Med 1981; 94: 395–400PubMed
42.
Fineberg H. Decision trees: construction, uses, and limits. Bull Cancer 1980; 67: 395–404PubMed
43.
Grinstead C, Snell J. Introduction to probability. Providence (RI): American Mathematical Society, 1997
44.
Sonnenberg F, Beck J. Markov models in medical decision making: a practical guide. Med Dec Mak 1993; 13: 322–338CrossRef
45.
Eckman M, Rosand J, Knudsen K, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003; 34: 1710–1716PubMedCrossRef
46.
Beck J, Pauker S. The Markov process in medical decision making. Med Decis Making 1983; 3: 419–458PubMedCrossRef
47.
48.
Lumina Decision Systems, Inc. [online]. Available from URL: http://​infolab.​umdnj.​edu/​windm/​ [Accessed 2007 Nov 27]
49.
50.
Bellman R. Dynamic programming. Mineola (NY): Dover Publications, 2003
51.
Marbach P, Tsitsiklis J. Simulation-based optimization of Markov reward processes (technical report LIDS-P 2411) [online]. Available from URL: http://​citeseer.​ist.​psu.​edu/​ 592383.html [Accessed 2007 Nov 27]
52.
Puterman M. Markov decision processes: discrete stochastic dynamic programming. Hoboken (NJ): John Wiley & Sons, Inc., 2005
53.
Feinberg EA, editor. Handbook of Markov decision processes: methods and applications. Boston (MA): Kluwer Academic Publishers, 2005
54.
Schaefer A, Bailey M, Shechter S, Roberts M. Modelling medical treatment using Markov decision processes. In: Brandeau ML, Sainfort F, Pierskalla WP, editors. Operations research and health care: a handbook of methods and applications. Boston (MA): Kluwer, 2004: 593–612
55.
56.
Pearl J. Causal inference in the health sciences: a conceptual introduction. Health Serv Outcomes Res Methodol 2001; 2: 189–220CrossRef
57.
Nease R, Owens D. Use of influence diagrams to structure medical decisions. Med Decis Making 1997; 17: 263–275PubMedCrossRef
58.
Owens D, Shachter R, Nease R. Representation and analysis of medical decision problems with influence diagrams. Med Decis Making 1997; 17: 241–262PubMedCrossRef
59.
Sonnenberg A, Collins J. Vicious circles in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 944–949PubMedCrossRef
60.
Meyer J, Phillips M, Cho P, et al. Application of influence diagrams to prostate intensity-modulated radiation therapy plan selection. Phys Med Biol 2004; 49: 1637–1653PubMedCrossRef
61.
MacDiarmid S, Pharo H. Risk analysis: assessment, management and communication. Rev Sci Tech 2003; 22: 397–408PubMed
62.
Coyle R. A systems approach to the management of a hospital for short-term patients. Socioecon Plann Sci 1984; 18: 219–226PubMedCrossRef
63.
64.
Forrester J. Industrial dynamics. Cambridge (MA): MIT Press, 1961
65.
Taylor K, Lane D. Simulation applied to health services: opportunities for applying the system dynamics approach. J Health Serv Res Policy 1998; 3: 226–232PubMed
66.
Hoard M, Homer J, Manley W, et al. Systems modelling in support of evidence-based disaster planning for rural areas. Int J Hyg Environ Health 2005; 208: 117–125PubMedCrossRef
67.
Edmunds W, Medley G, Nokes D. Evaluating the cost-effectiveness of vaccination programmes: a dynamic approach. Stat Med 1999; 18: 3263–3282PubMedCrossRef
68.
69.
Banks J, editor. Handbook of simulation. New York: John Wiley & sons, Inc., 1998
70.
71.
Minar N, Burkhart R, Langton C, et al. The Swarm simulation system: a toolkit for building multi-agent simulations [working paper 96-06-042]. Santa Fe (NM): Santa Fe Institute, 1996
72.
Tesfatsion L, Judd K, editors. Handbook of computational economics: 2. Agent-based computational economics. Amsterdam: North-Holland, Elsevier, 2006
73.
74.
75.
Christley R, Pinchbeck G, Bowers R, et al. Infection in social networks: using network analysis to identify high-risk individuals. Am J Epidemiol 2005; 162: 1024–1031PubMedCrossRef
76.
Christakis N. Social network analysis and collateral health effects. BMJ 2004; 329: 184–185PubMedCrossRef
77.
Christakis N, Fowler J. The spread of obesity in a large social network over 32 years. N Engl J Med 2007; 357: 370–379PubMedCrossRef
78.
Metadaten
Titel
Modelling Methods for Pharmacoeconomics and Health Technology Assessment
An Overview and Guide
verfasst von
Dr James E. Stahl
Publikationsdatum
01.02.2008
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 2/2008
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200826020-00004